Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-541-0 | CAS number: 12008-41-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Epidemiological data
Administrative data
- Endpoint:
- epidemiological data
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2014 - 2017
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
- Study type:
- cohort study (retrospective)
- Endpoint addressed:
- basic toxicokinetics
- developmental toxicity / teratogenicity
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- - Principle of test:
The study covers 199 voluntarily participating females with 326 children (162 girls and 164 boys), living in the South Marmara region of Turkey. The specific sampling areas of this study were Bandirma and Bigadic (Iskele) in the Balikesir district. The study aimed at assessing possible developmental effects mediated by environmental boron exposure in a population that included high environmental exposures to B in drinking water and food.
- Short description of test conditions: Boron content of drinking water and food, as well as blood boron content were sampled. Demographic information and information on pregnancy outcomes were obtained by a questionnaire survey. Included items were age, duration of marriage, preterm birth, numbers of children, birth weights of newborns, congenital anomalies, abortions, miscarriage, stillbirth, early neonatal death, neonatal death and infant death. Information on possible confounders (alcohol consumption, smoking, pesticide application) was also obtained. There is a time gap between the time of sampling ans the time of birth However, it was anticipated that the females were chronically exposed to an area-specific level of boron, at least since water monitoring started in this region about 20 years ago.
- Parameters analysed / observed: blood boron content, reproductive outcomes, birth weights and reproductive characteristics of females - GLP compliance:
- no
Test material
- Reference substance name:
- Boron
- Cas Number:
- 7440-42-8
- Molecular formula:
- B
- IUPAC Name:
- Boron
Constituent 1
Method
- Type of population:
- general
- Ethical approval:
- confirmed and informed consent free of coercion received
- Remarks:
- This study was approved by the Ethics committee of the Ankara University School of Medicine (no. 20-853-14, dated 08/12/2014). All participants gave their informed written consent prior to participation in the project.
- Details on study design:
- HYPOTHESIS TESTED (if cohort or case control study): The mean developmental parameters of the three groups (low, medium and high Boron exposure) are equal.
METHOD OF DATA COLLECTION
- Type: Questionnaire
- Details: Demographic information and information on pregnancy outcomes were obtained by a questionnaire survey. Included items were age, duration of marriage, preterm birth, numbers of children, birth weights of newborns, congenital anomalies, abortions, miscarriage, stillbirth, early neonatal death, neonatal death and infant death. Information on possible confounders (alcohol consumption, smoking, pesticide application) was also obtained.
STUDY PERIOD: 2014 - 2017
SETTING: Bandirma and Bigadic (Turkey)
STUDY POPULATION
- Total number of subjects participating in study: The study covers 199 voluntarily participating females with 326 children (162 girls and 164 boys), - Exposure assessment:
- estimated
- Details on exposure:
- TYPE OF EXPOSURE: environmental exposure
TYPE OF EXPOSURE MEASUREMENT: Area air sampling, Personal sampling (food, drinking water), Biomonitoring (urine, blood)
EXPOSURE LEVELS: 3.28 - 975.66 ng B/g blood
DESCRIPTION / DELINEATION OF EXPOSURE GROUPS / CATEGORIES: The study participants were classified into low, medium and high exposure groups, according to their blood boron concentrations. Females with blood boron concentrations lower than 100 ng B/g blood were classified as “low exposure group” (n = 143). Blood boron concentrations of 29 females ranged between 100 and 150 ng B/g blood; these were classified as “medium exposure group”. Females (n = 27) with concentrations higher than 150 ng B/g blood were classified as “high exposure group”. - Statistical methods:
- The different exposure groups were characterised by the mean, the empirical standard deviation, the range and the 5th and 95th quantile of B in blood. Moreover, boxplots, Pearson’s correlation coefficient, linear regression and spline regression display the empirical distribution and possible linear dependencies. Spline regression is a piecewise regression method, which is more flexible than linear regression and particularly suited to show within class effects, i.e. the effects in our three exposure groups. To investigate the global hypothesis that the means of the three groups are equal, a Kruskal–Wallis test is used. If the resulting p value was significant (p < 0.05), i.e. if the hypothesis of equal group means was rejected, the two-sided Wilcoxon–Mann–Whitney test as a post hoc test was applied to find distinct differences between each of the pairs of groups. The corresponding three p values were adjusted with the Bonferroni–Holm method for each variable to a count for the problem of multiple testing (Holm 1979). For the comparison of the reproductive outcomes the χ2 test was used. These nonparametric tests were deliberately employed as some of the variables showed outliers. All statistical tests were performed with R, version 3.4.1 (R Core Team 2017). The local as well as multiple significance levels of the tests were set at 0.05.
Results and discussion
- Results:
- Nevertheless, the spontaneous and induced abortion rates were lower in our study cohort than the average rates of the country and the average rates of the West Marmara region. A statistically significant boron-mediated increase in spontaneous and induced abortion rates between low, medium and high exposure groups was not visible (p > 0.05, χ2 test) as shown in Table 3.
In Turkey, according to the records in TDHS-2013, there were 0.9 stillbirths per 100 pregnancies. The percentage of stillbirth in our cohort was determined as 0.61 per 100 pregnancies (live births + stillbirths) and there was no significant (p > 0.05, χ2 test) boron-associated increase in stillbirth rates between the low, medium and high exposure groups (Table 3).
The infant mortality rate in Turkey was 13 deaths per 1000 live births, and the neonatal mortality rate was seven deaths per 1000 live births (TDHS-2013). Any early neonatal death or neonatal death was not observed in our study cohort (probably due to the low sample size), while the infant death rate was 1.2 per 100 live births (Table 3). The infant mortality rate of our cohort was lower than the average rate of Turkey, and a boron-associated statistically significant (p > 0.05, χ2 test) increase with exposure was not visible.
According to the UN World Health Statistics-(2014), the preterm birth rate per 100 live births in Turkey was 12. The preterm birth rate in our study cohort was 5.2 per 100 live births (Table 3) and a boron-associated statistically significant (p > 0.05, χ2 test) increase with exposure groups was not visible.
The prevalence of major congenital anomalies in Europe has been reported as 23.9 per 1000 births for 2003–2007 (Dolk et al. 2010). Unfortunately, figures on congenital anomalies covering all regions of Turkey are not available. However, the rate of congenital anomalies recorded for our study area (2.4 per 100 birth) was in line with the results of Europe, and boron-mediated statistically significant differences (p > 0.05, χ2 test) between low, medium and high exposure groups were not apparent (Table 3).
According to the report of Turkey Demographics Profile (2017), the sex ratio at birth in Turkey is 1.05 males/female. Within our study population, the mothers had 326 children, and 164 being male. Accordingly, the male/female sex ratio of 1.01 in our study population is in line with the report of Turkey Demographics Profile. The sex ratio in the high exposure group was 1.25. This ratio does not support a tendency in sex ratio at birth towards females, as claimed in earlier studies for a similarly boron-exposed population in China.
The prevalence of LBW and VLBW was 34 and 4, respectively, in our cohort and a statistically significant boron-associated adverse effect on these parameters could not be seen, even in the high exposure group (Table 3). The birth weights were also assessed as continuous variables, and the mean birth weights of infants (girls, boys and girls + boys) were compared between the exposure groups as shown in Table 4. The mean birth weights of newborns were statistically not different (p > 0.05) between the exposure groups. Possible boron-mediated effects on the birth weights of newborns were also analysed using linear spline regression models with two knots at 100 and 150 ng B/g blood. The association between birth weights and blood boron concentrations was negative between blood boron concentrations of 100 and 150 ng/g. An increase of 1 ng B/g blood was associated with a reduction in birth weight of 4.1 g between these blood boron concentrations. However, this association was statistically not significant, as shown in Table 5.
Any other information on results incl. tables
Table 1 Boron concentrations in blood/urine samples and the estimated DBE levels of the voluntary females | ||||
Boron exposure groups (ng B/g blood) | Blood (ng B/g blood) | DBE (mg B/day) | ||
Mean ± SD (min-max) | 5th-95th percentile | Mean ± SD (min-max) | 5th-95th percentile | |
Low (L), < 100, n = 143 | 39.74 ± 27.60 (3.28-99.28) | 3.62-93.40 | 9.73 ± 5.29* (2.26-38.27) | 2.30-17.37 |
Medium (M), 100-150, n = 29 | 124.19 ± 13.10 (100.35-146.74) | 105.35-143.43 | 21.62 ± 7.87* (8.08-39.71) | 10.14-34.80 |
High (H), > 150, n = 27 | 274.58 ± 213.00 (151.81-975.66) | 152.92-762.89 | 24.67 ± 11.39* (10.47-57.86) | 11.29-49.14 |
DBE daily boron exposure, SD standard deviation *The means are signiicantly diferent, p < 0.05, (L-M, L-H). Kruskal-Wallis test for global comparison. Wilcoxon-Mann-Whitney test with Bonferroni-Holm correction as post hoc test |
Table 2 Mean boron concentrations in water and food samples from the Bigadic area | |||
Samples | Low exposure group | Medium exposure group | High exposure group |
Mean ± SD (min-max) | Mean ± SD (min-max) | Mean ± SD (min-max) | |
Boron concentrations in drinking water samples taken from the residents, mg B/L | 0.74 ± 1.03 (LOQ-3.86) | 2.35 ± 0.95 (0.67-5.00) | 3.99 ± 2.44 (1.69-12.20) |
Boron concentrations in meal samples taken from lunch, mg B/ food* | 1.18 ± 1.22 (0.02-5.90) | 2.92 ± 3.32 (0.02-8.20) | 3.37 ± 3.52 (0.02-12.09) |
Boron concentrations in meal samples taken from dinner, mg B/ food* | 1.57 ± 1.87 (0.02-6.10) | 2.29 ± 2.92 (0.06-7.72) | 2.76 ± 3.67 (0.02-22.14) |
*Mean boron concentrations in the equal amount of meal samples consumed by the females in the lunch and dinner menus. A menu includes three dishes served together in both lunch and dinner |
Table 3 Reproductive outcomes | |||||
Parameters | (T) Total population (n = 199) | (L) Low exposure (n=143) | (M) Medium exposure (n = 29) | (H) High exposure (n= 27) | p value* |
Sum | Sum | Sum | Sum | ||
Number of children | 326 | 215 | 57 | 54 | > 0.05 |
Number of girls | 162 | 105 | 33 | 24 | > 0.05 |
Number of boys | 164 | 110 | 24 | 30 | > 0.05 |
Sex ratio, male/female | 1.01 | 1.05 | 0.72 | 1.25 | > 0.05 |
Low body weight (LBW), < 2500 g | 34 | 21 | 6 | 7 | > 0.05 |
Very low body weight (VLBW), < 1500 | 4 | 2 | 1 | 1 | > 0.05 |
Number of childless women | 15 | 14 | 1 | 0 | > 0.05 |
Number of pregnant women | 6 | 6 | 0 | 0 | > 0.05 |
Preterm birth | 17 | 12 | 1 | 4 | > 0.05 |
Congenital anomalies | 8 | 6 | 1 | 1 | > 0.05 |
Induced abortion | 23 | 18 | 4 | 1 | > 0.05 |
Spontaneous abortion (miscarriage) | 33 | 21 | 6 | 6 | > 0.05 |
Stillbirth | 2 | 0 | 1 | 1 | > 0.05 |
Early neonatal death | 0 | 0 | 0 | 0 | - |
Neonatal death | 0 | 0 | 0 | 0 | - |
Infant death | 4 | 2 | 2 | 0 | > 0.05 |
*Statistical comparisons were performed between the low, medium and high exposure groups; x2 tests were used to determine the statistical significance between the groups |
Table 4 Birth weights and reproductive characteristics of females | |||||||
Parameters | (L) Low exposure (n = 143) | (M) Medium exposure(n= 29) | (H) High exposure(n= 27) | p value | |||
Mean ± SD (min-max) | 5th-95th per-centile | Mean ± SD (min-max) | 5th-95th per- centile | Mean ± SD (min-max) | 5th-95th per- centile | ||
Age of mothers | 32.31 ± 6.77 (17-49) | 23.00-44.90 | 36.28 ± 6.95 (23-49) | 24.40-46.60 | 34.56 ± 6.10 (24-46) | 26.00-44.70 | < 0.05 (L-M) |
Duration of marriage, year | 11.17 ± 7.02 (0.66-29) | 2.00-25.00 | 16.61 ± 7.73 (0.58-29) | 3.20-28.60 | 14.81 ± 8.64 (3-42) | 5.30-28.10 | < 0.05 (L-M) |
Birth weight of newborns, g | 3213 ± 561 (1140-5000) | 2200-4000 | 3083 ± 563 (1400-4200) | 1950-3820 | 3112 ± 709 (1200-4750) | 2000-4000 | > 0.05 |
Birth weight of newborns, girls, g | 3154 ± 536 (1140-4250) | 2600-3919 | 2991 ± 615 (1400-4000) | 1690-3840 | 3057 ± 674 (2000-4000) | 2015-4000 | > 0.05 |
Birth weight of newborns, boys, g | 3269±580 (1400-5000) | 2250-4000 | 3209 ± 464 (2000-4200) | 2703-3800 | 3142 ± 745 (1200-4750) | 1725-4055 | > 0.05 |
*Kruskal-Wallis test for global comparison. Wilcoxon-Mann-Whitney test with Bonferroni-Holm correction as post hoc test |
Table 5 Linear spline regression analysis between blood boron concentrations and birth weights of newborns | |||||
Birth weights of newborns | |||||
Estimate | Std. error | t | Slope | pvalue | |
Intercept | 3192.09 | 64.77 | 49.28 | < 2e-16 | |
Low exposure | 40.65 | 120.34 | 0.34 | 0.4203 | 0.74 |
Medium exposure | - 166.88 | 98.34 | - 1.70 | - 4.0693 | 0.09 |
High exposure | 207.03 | 281.08 | 0.74 | 0.4534 | 0.46 |
Table 6 Linear regression analysis for the birth weight of newborns | ||||
Total study group | ||||
Estimate | Std. error | t | p value | |
Intercept, (β0) | 3517.58 | 194.36 | 18.10 | < 2e-16 |
Blood boron conc., (β1) | 0.01 | 0.27 | 0.02 | 0.98 |
Alcohol consumption, (β2) | - 138.49 | 74.02 | - 1.87 | 0.06 |
Age,(β3) | - 7.94 | 5.45 | - 1.46 | 0.147 |
Smoking during pregnancy, (β4) | - 279.77 | 139.60 | - 2.01 | 0.04 |
Smoking,(β5) | 12.28 | 93.87 | 0.13 | 0.89 |
Pesticide application,(β6) | 145.07 | 88.37 | 1.64 | 0.10 |
Applicant's summary and conclusion
- Conclusions:
- In spite of the high level of daily boron exposure, boron-mediated adverse effects on induced abortion, spontaneous abortion (miscarriage), stillbirth, infant death, neonatal death, early neonatal death, preterm birth, congenital anomalies, sex ratio and birth weight of newborns were not observed.
- Executive summary:
Boric acid and sodium borates are currently classified as being toxic to reproduction under “Category 1B” with the hazard statement of “H360 FD” in the European CLP regulation. This has prompted studies on boron-mediated reprotoxic effects in male workers in boron mining areas and boric acid production plants. By contrast, studies on boron-mediated developmental effects in females are scarce. The present study was designed to fill this gap. Hundred and ninety nine females residing in Bandirma and Bigadic participated in this study investigating pregnancy outcomes. The participants constituted a study group covering blood boron from low (< 100 ng B/g blood, n = 143) to high (> 150 ng B/g blood, n = 27) concentrations. The mean blood boron concentration and the mean estimated daily boron exposure of the high exposure group was 274.58 (151.81–975.66) ng B/g blood and 24.67 (10.47–57.86) mg B/day, respectively. In spite of the high level of daily boron exposure, boron-mediated adverse effects on induced abortion, spontaneous abortion (miscarriage), stillbirth, infant death, neonatal death, early neonatal death, preterm birth, congenital anomalies, sex ratio and birth weight of newborns were not observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
